Sjs Investment Consulting Inc. Neogenomics Inc Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 11 shares of NEO stock, worth $165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 22
50.0%
Holding current value
$165
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$296 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$211 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$104 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$99.3 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$98.4 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.89B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...